Enveda
Biotech startup using AI to discover new drugs in the natural world
Enveda is a biotech & life sciences company, founded in 2019. It has raised $311 million in disclosed funding. Its latest round was a Series E of $311 million in September 2026.
Overview
No overview yet. It is written from sources once there are enough of them.
Funding
Total disclosed: $311M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Enveda do?
Biotech startup using AI to discover new drugs in the natural world
How much has Enveda raised?
Enveda has raised $311 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Enveda?
Investors in Enveda include Catalio Capital Management and Iconiq.
When and where was Enveda founded?
Enveda was founded in 2019.
Timeline
Founded
Sources
- 1.Enveda secures $311M to bring more nature-derived AI drugs into clinical trials — TechCrunch Startups, Sep 23, 2026